Anti-K0100/ KIAA0100/ BCOX functional antibody

Anti-K0100/ KIAA0100/ BCOX functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KIAA0100/KIAA0100 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0294-Ab-1/ GM-Tg-hg-SE0294-Ab-2Anti-Human KIAA0100 monoclonal antibodyHuman
GM-Tg-rg-SE0294-Ab-1/ GM-Tg-rg-SE0294-Ab-2Anti-Rat KIAA0100 monoclonal antibodyRat
GM-Tg-mg-SE0294-Ab-1/ GM-Tg-mg-SE0294-Ab-2Anti-Mouse KIAA0100 monoclonal antibodyMouse
GM-Tg-cynog-SE0294-Ab-1/ GM-Tg-cynog-SE0294-Ab-2Anti-Cynomolgus/ Rhesus macaque KIAA0100 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0294-Ab-1/ GM-Tg-felg-SE0294-Ab-2Anti-Feline KIAA0100 monoclonal antibodyFeline
GM-Tg-cang-SE0294-Ab-1/ GM-Tg-cang-SE0294-Ab-2Anti-Canine KIAA0100 monoclonal antibodyCanine
GM-Tg-bovg-SE0294-Ab-1/ GM-Tg-bovg-SE0294-Ab-2Anti-Bovine KIAA0100 monoclonal antibodyBovine
GM-Tg-equg-SE0294-Ab-1/ GM-Tg-equg-SE0294-Ab-2Anti-Equine KIAA0100 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0294-Ab-1/ GM-Tg-hg-SE0294-Ab-2; GM-Tg-rg-SE0294-Ab-1/ GM-Tg-rg-SE0294-Ab-2;
GM-Tg-mg-SE0294-Ab-1/ GM-Tg-mg-SE0294-Ab-2; GM-Tg-cynog-SE0294-Ab-1/ GM-Tg-cynog-SE0294-Ab-2;
GM-Tg-felg-SE0294-Ab-1/ GM-Tg-felg-SE0294-Ab-2; GM-Tg-cang-SE0294-Ab-1/ GM-Tg-cang-SE0294-Ab-2;
GM-Tg-bovg-SE0294-Ab-1/ GM-Tg-bovg-SE0294-Ab-2; GM-Tg-equg-SE0294-Ab-1/ GM-Tg-equg-SE0294-Ab-2
Products NameAnti-KIAA0100 monoclonal antibody
Formatmab
Target NameKIAA0100
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KIAA0100 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0294-Ag-1Recombinant multi-species K0100/ KIAA0100/ BCOX protein


    Target information

    Target IDGM-SE0294
    Target NameKIAA0100
    Gene ID9703,72503,303280,709307,480625,101085330,517133,100072067
    Gene Symbol and Synonyms2610507B11Rik,BCOX,BCOX1,BLTP2,CT101,D11Bhm178e,D11Bhm179e,E1,FMP27,Hob,KIAA0100,mKIAA0100,RGD1307929
    Uniprot AccessionQ14667
    Uniprot Entry NameK0100_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000007202
    Target ClassificationN/A

    The target: KIAA0100, gene name: KIAA0100, also named as BCOX, BCOX1, CT101, FMP27. This gene was initially characterized in human as having high expression levels in breast carcinomas and breast cancer cell lines. This gene also has increased expression in prostrate cancer cells relative to normal prostrate tissues. Expression of this gene is negatively regulated by direct binding of the microRNA miR-195 to its 3' UTR. miR-195 has been shown to modulate the invasiveness of prostrate cancer cells and xenograft metastases by downgrading expression of this gene. In mouse, the protein encoded by this gene was identified as an antigen on acute monocytic leukemia cells. In human, alternative splicing results in multiple transcript variants encoding distinct isoforms; some of these isoforms are predicted to contain an RNA pol II promoter FMP27 protein domain and a Golgi-body-localization APT1 domain. [provided by RefSeq, Apr 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.